Article Details
Retrieved on: 2024-06-15 21:48:34
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Actinium Pharmaceuticals' efforts in developing biopharmaceutical treatments using biotech, specifically focusing on Iomab-B’s positive trial results for AML. This aligns with the tags 'Biopharmaceutical' and 'Actinium Pharmaceuticals Inc.'
Article found on: markets.businessinsider.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here